--> --> -->

Global Heart Failure Disease Market Analysis, 2020

Drug (Beta Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers, Diuretics, Inotropic Agents, Aldosterone Antagonist, Calcium Channel Blockers, Others (Milrinone and Flosequinan, etc.)) Surgery, Medical Devices (Ventricular Assist Device (VAD), Pacemaker, Implantable Cardioverter-Defibrillators (ICD), Continuous Positive Air Pressure Device (CPAP), Bi-Level Positive Air Pressure Device (BiPAP), Heart Pumps, By Diagnostic Test (Blood Test, Electrocardiogram (ECG), Echocardiogram, Chest X-ray, CT Scan & MRI, Others (Myocardial Biopsy, stress test, etc.) By Age Group (Upto 30 years, 31 - 64 years, 65 Years & Above), By Gender (Male, Female), By Region (North America (US, Canada, Mexico) South America (Argentina, Brazil) Europe (UK, Germany, France, Italy, Netherland, Spain, Rest of Europe) Asia-Pacific (China, Australia, Japan, India, South-East Asia, South Korea) Middle East and Africa (UAE, Saudi Arabia, South Africa)

  • Healthcare
  • Jun 2020
  • 211
  • HC22019